Early 2026 has seen a surge in direct-to-consumer genomic testing. As highlighted by the Rockefeller Institute (2026), this trend is shifting the burden of data interpretation onto primary care providers who must now manage unverified clinical data from third party med tech companies.
The Question: Should medical students be trained to validate raw genomic data from third-party apps, and if so, how does this change the doctor/patient relationship?
For Discussion:
A patient presents a third-party DNA report claiming a high risk for a rare cardiovascular condition that traditional tests don't support.
- How do you teach a student to manage the patient's digital health anxiety without performing unnecessary, high-cost medical procedures that the data doesn't scientifically warrant?
